PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2013; 8(2): e56898.
Published online Feb 19, 2013. doi:  10.1371/journal.pone.0056898
PMCID: PMC3576386
Rs4074134 Near BDNF Gene Is Associated with Type 2 Diabetes Mellitus in Chinese Han Population Independently of Body Mass Index
Xueyao Han, Yingying Luo, Xiuying Zhang, Chao Lv, Xiuqin Sun, Xiaomei Zhang, Xianghai Zhou, Xiaoling Cai, Qian Ren, and Linong Ji*
Department of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing, China
Aimin Xu, Editor
University of Hong Kong, China
* E-mail: jiln/at/bjmu.edu.cn
Competing Interests: The authors have declared that no competing interests exist.
Conceived and designed the experiments: JL HX. Performed the experiments: HX LY Z. Xiuying LC. Analyzed the data: HX. Contributed reagents/materials/analysis tools: SX Z. Xiaomei Z. Xianghai RQ CX. Wrote the paper: HX.
Received November 17, 2012; Accepted January 15, 2013.
Obesity and family history are the most important predictors for type 2 diabetes mellitus(T2DM) in the Chinese Han population. However, it is not known whether the genetic loci related to obesity are associated with the risk of developing T2DM in this population. The present case-control study evaluated the associations between five genetic loci for obesity and the pathogenesis of T2DM. The study included 1117 Chinese Han patients with T2DM, 1629 patients with pre-diabetes (impaired fasting glucose and impaired glucose tolerance, IFG/IGT) and 1113 control subjects residing in Beijing. Five genetic loci including rs2815752 near NEGR1, rs10938397 near GNPDA2, rs4074134 near BDNF, rs17782313 near MC4R and rs1084753 near KCTD15 were genotyped. The results showed an association between rs4074134-BDNF minor allele and T2DM irrespective of age, gender and body mass index (BMI) (OR = 0.87; 95%CI: 0.77–0.99, P = 0.04). This SNP was also associated with pre-diabetes (OR = 0.87; 95%CI: 0.77–0.97, P = 0.01) independently of age, gender and BMI. No associations were found between diabetes or pre-diabetes and any of the other SNP loci studied. Genotype–phenotype association analysis (adjusting for age and gender) showed rs4074134-BDNF to be associated with BMI, waist circumference, fasting and postprandial plasma glucose, fasting serum insulin, and HOMA-IR in subjects without T2DM. However, fasting and postprandial plasma glucose were the only significant factors after adjusting for BMI. These results suggest that the common variation of BDNF (rs4074134) is associated with T2DM independently of obesity in Chinese Han population. This variant also has an effect on plasma glucose concentration, BMI and insulin sensitivity.
Type 2 diabetes mellitus (T2DM) is characterized by chronic hyperglycemia and defects in the secretion and/or actions of insulin. Genetic and environmental factors play important roles in the development of T2DM. Recent studies indicate that the prevalence of T2DM and obesity are dramatically increasing. It has been estimated that 92.4 million adults in China have diabetes, and that 148.2 million adults have pre-diabetes [1]. The same study identified a family history of T2DM and obesity as two of the most important risks for T2DM in Chinese patients [1].
The increasing prevalence of obesity is caused by the excessive calorie intake and diminished physical activity in the modern environment. However, available evidence also suggests a significant genetic contribution to adiposity [2]. The heritability for high body mass index (BMI) and large waist circumference is high (h2:0.60–0.63), and shared genetic factors have been identified in Chinese subjects patients that determine BMI, glucose homeostasis traits and insulin resistance index [3]. During the last 5 years, increasing numbers of genetic loci associated with obesity and/or BMI have been identified as a result of the genome-wide association study (GWAS). These loci include: FTO, Mc4R, TMEM18, NEGR1, GNPDA2, BDNF, MTCH2 and BCDIN3D–FAIM2 [4][11]. It is widely recognized that, FTO, which increases the risk for obesity, is also a susceptibility gene for T2DM [12][16]. It is notable that the association between FTO and T2DM remains statistically significant in Asian population even after adjusting for BMI [15],[17] but this is not the case in European studies [12],[13]. The difference may be attributed to the different genetic background among races.
Interventions, including life style modification and anti-diabetic drugs such as metformin, sulphonylurea and insulin, that have strong effects on BMI, would be expected to distort the relationship between BMI, genetic variation and T2DM. It is, therefore, possible that adjustment for BMI during logistic analysis in previous association studies identifying susceptibility genes for T2DM may have masked important risk loci for T2DM.
For these reasons it was of interest to evaluate the contribution of other loci associated with obesity in Chinese Han population. There is also a large population of subjects with pre-diabetes (impaired fasting glucose (IFG) or/and impaired glucose tolerance (IGT)) who are not currently taking anti-diabetic drugs. We, therefore, designed a case-control study consisting of controls with normal oral glucose test (OGTT) and patients with pre-diabetes in an attempt to identify associations between T2DM and five genetic loci near NEGR1, GNPDA2, BDNF, MC4R and KCTD15 that have previously been reported to be associated with obesity or/and BMI [8][11].
Participants
A total of 3919 subjects of Northern Han Chinese ancestry residing in Beijing were included in the study. All subjects had attended the Endocrinology Departments of hospitals in Beijing. The population included 2806 unrelated subjects,1177 subjects with T2DM and 1629 with pre-diabetes. Diabetes and pre-diabetes were diagnosed in accordance with the 1999 World Health Organization criteria. Patients diagnosed with T2DM or pre-diabetes before 30 years of age, with a body mass index (BMI)>35 kg/m2, or clinical findings consistent with type 1 diabetes or other specific forms of diabetes (e.g., maturity onset diabetes of the young) were excluded from the study.
An additional 1113 control subjects >40 years of age, and with a BMI≤35 kg/m2 were recruited from Beijing. These subjects had normal glucose tolerance confirmed by a 75-g oral glucose tolerance test (OGTT) according to the 1999 World Health Organization criteria (fasting plasma glucose <6.1 mmol/L and 2-h plasma glucose <7.8 mmol/L), and had no family history of T2DM (3). The baseline clinical characteristics of subjects in all three groups are summarized in Table 1.
Table 1
Table 1
Subject characteristics.
All participants provided written informed consent, and the study protocol was approved by the Ethics Committee of Peking University People's Hospital.
Anthropometric and biochemical measurements
All subjects were examined in the morning after a 10 to 12 h overnight fast. Height, weight, waist circumference, hip circumference and blood pressure were measured. Blood samples were collected to measure fasting plasma glucose, and fasting serum insulin. Plasma glucose levels were measured using the glucose oxidase-peroxidase method. Fasting serum insulin levels were measured using a radioimmunoassay. Using the homeostasis model assessment (HOMA), insulin resistance index (HOMA-IR) was calculated as fasting insulin (mU/L)×fasting plasma glucose (mmol/L)/22.5, and β cell function (HOMA-β) was calculated as fasting insulin×20/(fasting plasma glucose - 3.5) [18].
DNA extraction and genotyping
Genomic DNA was extracted from peripheral blood leukocytes using a precipitation method. As rs2815752 near NEGR1, rs10938397 near GNPDA2, rs4074134 near BDNF, rs17782313 near MC4R and rs1084753 near KCTD15 have been reported to be associated with obesity in Caucasian subjects [8][11]. We explored the roles of these SNPs in a Chinese population. SNP rs2815752 is located on chromosome 1 near (~65 kb 5′-flanking of) NEGR1; SNP rs10938397 is in a gene desert ~500 kb from GNPDA2 on chromosome 4; SNP rs4074134 is located on chromosome 11 near (~31 kb 3′-flanking of) BDNF; SNP rs17782313 is in 188 kb downstream of MC4R; SNP rs11084753 is located on chromosome 11 near (~17 kb 3′-flanking of) KCTD15.
These SNPs were genotyped using a MassARRAY iPLEX system (MassARRAY Compact Analyzer, Sequenom, San Diego, CA, USA). Overall, 5% of the DNA samples were duplicated in genotyping for quality control. The call rates for all these SNPs were more than 95%,and the concordance rates were more than 98%.
Statistical analysis
All statistical tests were performed using PLINK, version 1.07 (http://pngu.mgh.harvard.edu/~purcell/plink) and SPSS software version 16.0 for Windows (SPSS, Chicago, IL, USA. Continuous variables were presented as means and standard deviations (±SD) if normally distributed, or as medians (interquartile range) if non-normally distributed. Categorical variables were presented as numbers and percentages. Fasting serum insulin, 2-h serum insulin, HOMA-IR and HOMA-β were subjected to natural logarithm transformation to obtain a normal distribution prior to statistical analysis.
Between-group differences in clinical characteristics were analyzed using Student's t tests or ANOVA for continuous variables. Chi square tests were used to determine whether polymorphisms were in Hardy–Weinberg equilibrium. Differences in allele and genotype frequencies between the diabetic and control subjects were analyzed using Pearson's chi square test.
Logistic regression analysis was performed to calculate allele-specific odds ratios (OR) with 95% confidential intervals (CI) after adjustment for gender, age and BMI as covariates. Quantitative trait association analyses were performed using multiple linear regressions adjusting for age, gender and BMI as covariates. Association analyses of BMI and waist circumference were adjusted for age and gender. Because of the low frequency of minor alleles for homozygote of rs2815752 (less than cases and less than 10 controls) a dominant model was used in logistic and linear regression analyses.In all hypothesis tests, two-tailed values of P<0.05 were considered statistically significant.
Power calculation
The power calculation was performed using Quanto software version 1.2.4 (University of Southern California, Los Angeles, CA, USA). Based on the prevalence of T2DM in China of 9.7% [1], and using a additive genetic model, this study had 80% power at P<0.05 to detect an effect size of 1.27 for rs2815752, 1.17 for rs10938397, 1.16 for rs4074134, 1.19 for rs17782313 and 1.18 for rs11084753 on T2DM.
Association study on T2DM and pre-diabetes
The genotype frequencies of the five SNPs were in accordance with the Hardy–Weinberg equilibrium in the control groups except for rs10938397 (P = 0.04). Table 2 summarizes the results of the association study with T2DM. The minor allele frequencies (MAF) of these SNPs ranged from 0.1 to 0.44 in control subjects, which is comparable with values reported in the Hap Map database.
Table 2
Table 2
Logistic regression analysis of association of five SNPs with type2 diabetes and pre-diabetes.
There was a significant difference in allele frequency and genotype distribution between the patients and control subjects at rs4074134. Logistic analysis with A(MA) allele as a dependent variable showed that rs4074134 was associated with T2DM irrespective of age, gender or BMI (OR = 0.87; 9%CI: 0.77–0.99; P = 0.04) (also see Supplementary Table 1).
A similar association was also observed for rs4074134 when pre-diabetes was analyzed as the case group, (OR = 0.87; 95%CI: 0.77–0.97; P = 0.01). This was also independent of age, gender and BMI. However, we found no association between T2DM or pre-diabetes and any of the other four SNP loci. Logistic regression analysis, adjusting for age, gender and BMI and combining T2DM and pre-diabetes also resulted in a significant association between rs4074134 and T2DM or pre-diabetes (OR = 0.87; 95%CI: 0.79–0.97; P = 0.009) .
Association study on obesity
Subgroup analysis was performed to evaluate the association between SNPs (excluding rs10938397 which was not in Hardy-Weinberg equilibrium) and obesity in Chinese Han population. To remove the influence of anti-diabetic drug use on this analysis, only subjects with pre-diabetes and control subjects were included in this analysis. Based on diagnostic criteria for obesity specific for Chinese patients [19], the subjects were classified into three groups: a normal weight group (BMI<24 kg/m2), an overweight group (BMI 24 to 28 kg/m2) and an obese group (BMI≥28 kg/m2).
The allele and genotype distributions (shown in Supplementary Table 2) were in accordance with Hardy-Weinberg equilibrium in the normal weight group. A case control study between the normal weight and obesity group identified an association between obesity and rs4074134 in subjects with a normal OGTT (OR = 0.70; 95%CI: 0.55–0.90; P = 0.004) and the in the pooled population without T2DM (OR = 0.79; 95%CI: 0.68–0.92; P = 0.002). We also observed a non-significant association between obesity and rs17782313 in the controls subjects (OR = 1.28; 95%CI: 0.97–1.69; P = 0.08) and in the pooled group of controls and subjects with pre-diabetes (OR = 1.16; 95%CI: 0.98–1.38; P = 0.08). No association was observed between obesity and any of the other SNPs either with or without adjustment for age and gender(Table 3).
Table 3
Table 3
Logistic regression analysis of association of five SNPs with obesity in subjects without diabetes.
Genotype–phenotype association analysis
To avoid the influence of anti-diabetic treatment, genotype–phenotype association analysis was only undertaken in the control and pre-diabetes groups. In this analysis we investigated differences among genotypes of T2DM-related quantitative traits including BMI, waist circumference, fasting and postprandial plasma glucose, fasting and postprandial serum insulin, HOMA-β and HOMA-IR.
Subjects in the control group without the A allele for rs4074134 had a higher BMI than the subjects with the A allele (AA: 25.0±3.1 kg/m2; AG: 25.1±3.1 kg/m2; GG: 25.6±3.4 kg/m2; P = 0.029). No significant differences in other metabolic traits were found among genotypes. In the subjects with pre-diabetes, there were no significant differences among genotypes for any of the above metabolic traits (data not shown).
Analysis pooling data from control and subjects with pre-diabetes showed that BMI, waist circumference, fasting and postprandial plasma glucose, fasting serum insulin, and HOMA-IR were all higher in subjects without the A allele than in those with the A allele (Table 4).
Table 4
Table 4
Comparison of T2DM-related traits among genotypes of rs4074134 in subjects without T2DM.
Linear regression analyses adjusting for age and gender identified and associations between rs4074134 and BMI, waist circumference, fasting and postprandial plasma glucose, fasting serum insulin, and HOMA-IR. Analysis with adjustment of BMI showed that the association remained only for fasting and postprandial plasma glucose (Table 5).
Table 5
Table 5
Linear regression analyses between rs4074134 and T2DM-related phenotypes.
We evaluated the contribution of five variants near five genes of NEGR1, GNPDA2, BDNF, MC4R and KCTD15 to the development of T2DM in a Chinese Han population. We replicated a previously reported association between BDNF-rs4074134 and obesity. We also observed that this SNP was associated with not only T2DM and hyperglycemia but also the other metabolic features such as waist circumference, fasting serum insulin level and insulin resistance.
Obesity is a complex condition caused by genetic and environmental factors, and is an important predicator for T2DM. FTO was the first susceptibility gene for obesity to be identified and together with BMI was reported to be associated with T2DM [12],[13] in European Caucasian subjects. FTO genetic variants have been reported to be associated with T2DM in several Asian studies. However, its role in the Asian population as a whole is not so important as in Caucasians because the risk allele frequencies are much lower in Asian than in Caucasian populations [14][16].
In a previous study we demonstrated an association between the FTO gene and T2DM in Chinese Han patients even after adjusting for BMI [15]. This observation was confirmed by a recently published large-scale meta-analysis of FTO in Asian subjects [17]. This hypothesis has also been verified by recent studies showing that GNPDA2, BCDIN3D/FAIM2, SH2B1, FTO, KCTD15 and BDNF were associated with T2DM and BMI in Han Chinese patients in Hong Kong [20]. Other workers have shown SEC16B, TMEM18, GNPDA2, BDNF, MTCH2, BCDIN3D–FAIM2, SH2B1–ATP2A1, FTO, MC4R, KCTD15 to be associated with T2DM and BMI in Japanese subjects [21]. In Japanese subjects, but not in Han Chinese subject in Hong Kong, FTO, TMEM18, GNPDA2, BDNF, BCDIN3D were associated with T2DM independently of BMI [20],[21].
Differences in environmental risk profiles, body composition, and genetic background between Caucasian and Asian subjects may explain these various findings. Asian subject have been shown to be at risk for T2DM at lower levels of obesity than Caucasians, partly due to increased predisposition to visceral adiposity [22] and reduced pancreatic β-cell function [23]. Unaccounted for differences in the treatment of T2DM also explain the inconsistent results, as insulin increases and metformin decreases BMI. Statistical adjustment for BMI may therefore have an unpredictable effect on the power to identify genetic loci of T2DM and obesity. Indeed, a recent analysis stratified according to BMI reported a novel locus in LAMA1 for T2DM in lean subjects [24].
Most subjects with pre-diabetes eventually develop diabetes unless intervention is undertaken. In our study, we included patients with pre-diabetes as a case group, in order to reduce the interference of diabetes treatment and properly evaluate the contribution of the genetic variations associated with BMI in the pathogenesis of T2DM. We showed that BDNF genetic variation was associated with pre-diabetes independently of BMI, and in accordance with its association with T2DM and hyperglycemia. Subsequent phenotype and genotype relationship analysis indicated rs4074134 or other variations in linkage equilibrium might affect insulin sensitivity rather than beta cell function, which in turn may alter the risk for pre-diabetes and T2DM.
A large study in 18014 middle aged Danish subjects examined 15 genetic variations from 14 loci and showed that the A allele of rs4923461 displayed a borderline BMI-dependent protective effect on T2DM, whereas SH2B1 rs7498665 was associated with a nominally BMI-independent increased risk of T2DM [25]. Another large-scale European study in 34840 patients with T2DM and 114981 controls identified a SNP (rs12970134) of MC4R, which is in strong LD with variants associated with BMI [8],[11], as a new T2DM susceptibility loci with genome-wide significance [26]. These findings suggest that different pathophysiologic pathways involved in obesity play a role in development of T2DM in different ethnic groups.
BDNF is a member of the neurothrophin family of growth factors [27], which has a high affinity for the tropomyosin-related kinase B (TrkB) receptor [28]. BDNF is abundantly expressed throughout the developing and mature CNS and in many peripheral tissues, including muscle, liver and adipose, where it modulates energy metabolism and feeding behavior [29],[30],[31], [32]. Animals with reduced BDNF expression due to a conditional knockout in the brain develop hyperphagia, obesity and resistance to insulin [33],[34]. Intracerebroventricular administration of BDNF has been shown to decrease energy intake and body weight in rats, and to reverse the hyperphagic and obese phenotype of BDNF mutant mice [33]. It has also been shown to lower blood glucose and enhance energy expenditure in db/db mice via activation of the sympathetic nervous system [35].
WAGR syndrome in humans is characterized by heterozygous gene deletions near BDNF. All affected subjects who are heterozygous for BDNF become obese by the age of 10 [36]. A published case report describes a de novo chromosomal inversion, 46,XX,inv(11)(p13p15.3) (a region encompassing the BDNF gene) in an 8-year-old girl with hyperphagia, severe obesity, impaired cognitive function, hyperactivity and low serum concentration of BDNF protein [37]. These findings indicate that BDNF may play an important role in energy equilibrium, which is a key pathogenic factor in obesity and T2DM.
In previous studies, five SNPs including rs4074134, rs6265 (val66met), rs4923461, rs12291063 and rs925946 [9], [11], [20], [21] have been reported to be associated with obesity or/and BMI in Caucasian and Asian subjects. Another study reported an association between homozygosity for the minor C allele at rs12291063, reduced VMN BDNF expression and high BMI [38]. Low circulating levels of BDNF have been observed in individuals with both obesity and T2DM [39]. The same workers reported that plasma levels of BDNF were decreased in humans with T2DM, independently of obesity, suggesting that BDNF may regulate obesity and insulin resistance via different mechanisms [39].
The BDNF gene produces transcriptions with either short or long 3′ untranslated regions (3′-UTRs). It has been shown that long 3′UTR BDNF mRNA was enriched in the dentrites of hypothalamic neurons and that insulin and leptin could stimulate its translation in dentrites [40]. In these studies, mice harboring a truncated long BDNF 3′UTR developed severe hyperphagic obesity. These findings provide evidence indicating a relationship between BDNF mRNA with a long 3′UTR, leptin, neuronal activation and body weight, suggesting targeted BDNF mRNA is essential for energy balance and response to leptin [40]. These variations in BDNF structure might affect its protein activity and mRNA transcription pattern in a way that increases the risk for obesity and T2DM. Chinese subjects with the risk allele of BDNF might have limited ability to resist excess food intake and subsequently develop T2DM. These subjects also have increased predisposition to visceral adiposity and reduced pancreatic β-cell function [1],[22],[23].
A meta-analysis of associations between BMI and approximately 2.4 million SNPs in 27,715 East Asian subjects with replication studies in 37,691 and 17,642 additional East Asian subjects confirmed that loci at MC4R and BDNF were associated with obesity [41]. The loci in the GNPDA2 nearly reached the genome-wide significance [41]. Our study population was much smaller than that in the meta-analysis. However, we confirmed the association between BDNF, obesity and BMI but found no significant associations for the other four genetic loci. There was, however, a tendency towards an association between MC4R, obesity and BMI.
It is likely that our study lacked power to adequately evaluate the other four loci possibly due to differences in genetic background among races. In the published studies in Chinese Han subjects, only one study from Hong Kong [20] evaluated the relationship between these five genetic loci and T2DM, and only ETV5/DGKG (rs7647305) was found to be associated with T2DM independently of BMI. It is notable that the SNPs near BDNF that were studied were different from those in our investigation, also suggesting possible differences between Han populations from Hong Kong and Beijing in China.
In conclusion, we demonstrated that a common variation of BDNF is associated with T2DM independently of obesity in the Chinese Han population. This variant has an effect on plasma glucose concentration, BMI and insulin resistance.
Supporting Information
Table S1
The distribution of genotypes of five studied SNPs in subjects with normal glucose tolerance and pre-diabetes.
(DOCX)
Table S2
The distribution of genotypes of five studied SNPs in subjects with different body mass index.
(DOCX)
Acknowledgments
We would like to express our thanks to the subjects for agreeing to participate in this study and to all the researchers involved in this study.
Funding Statement
This work was supported by funds from the National High Technology Research and Development Program (863 program, 2006AA02A409,2012AA02A509), Beijing Science&Technology Committee(D0905003040131 and D090507046410012), the National Basic Research Program of China (2011CB504001) and the National Natural Science Foundation of China (30771031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
1. Yang W, Lu J, Weng J, Jia W, Ji L, et al. (2010) China National Diabetes and Metabolic Disorders Study Group: Prevalence of diabetes among men and women in China. N Engl J Med 362: 1090–1101. [PubMed]
2. Loos RJ, Bouchard C (2003) Obesity–is it a genetic disorder? J Intern Med 254: 401–425. [PubMed]
3. Li JK, Ng MC, So WY, Chiu CK, Ozaki R, et al. (2006) Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes Metab Res Rev 22: 46–52. [PubMed]
4. Dina C, Meyre D, Gallina S, Durand E, Korner A, et al. (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39: 724–726. [PubMed]
5. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316: 889–894. [PMC free article] [PubMed]
6. Hinney A, Nguyen TT, Scherag A, Friedel S, Brönner G, et al. (2007) Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS ONE 2: e1361. [PMC free article] [PubMed]
7. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, et al. (2007) Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 3: e115. [PubMed]
8. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, et al. (2008) Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 40: 768–775. [PMC free article] [PubMed]
9. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, et al. (2009) Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 41: 18–24. [PubMed]
10. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, et al. (2009) Genetic Investigation of Anthropometric Traits Consortium. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 41: 25–34. [PMC free article] [PubMed]
11. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, et al. (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42: 937–948. [PMC free article] [PubMed]
12. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341–1345. [PMC free article] [PubMed]
13. Robiou-du-Pont S, Bonnefond A, Yengo L, Vaillant E, Lobbens S, et al. (2012) Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population. Int J Obes doi:10.1038/ijo.2012.175. [PubMed]
14. Ng MC, Park KS, Oh B, Tam CH, Cho YM, et al. (2008) Implication of genetic variants near TCF7L2,SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 57: 2226–2233. [PMC free article] [PubMed]
15. Han X, Luo Y, Ren Q, Zhang X, Wang F, et al. (2010) Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1,and WFS1 in type 2 diabetes in a Chinese population. BMC Med Genet 11: 81. [PMC free article] [PubMed]
16. Horikawa Y, Miyake K, Yasuda K, Enya M, Hirota Y, et al. (2008) Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab 93: 3136–3141. [PubMed]
17. Li H, Kilpeläinen TO, Liu C, Zhu J, Liu Y, et al. (2012) Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia 55: 981–995. [PMC free article] [PubMed]
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419. [PubMed]
19. Cooperartive Meta-analysis Group of the Working Group on Obesity in China (2002) Predictive value of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults—study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15: 83–95. [PubMed]
20. Ng MC, Tam CH, So WY, Ho JS, Chan AW, et al. (2010) Implication of genetic variants near NEGR1, SEC16B, TMEM18, ETV5/DGKG, GNPDA2,LIN7C/BDNF, MTCH2, BCDIN3D/FAIM2, SH2B1, FTO, MC4R, and KCTD15 with obesity and type 2 diabetes in 7705 Chinese. J Clin Endocrinol Metab 95: 2418–2425. [PubMed]
21. Takeuchi F, Yamamoto K, Katsuya T, Nabika T, Sugiyama T, et al. (2011) Association of genetic variants for susceptibility to obesity with type 2 diabetes in Japanese individuals. Diabetologia 54: 1350–1359. [PubMed]
22. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, et al. (2006) Epidemic obesity and type 2 diabetes in Asia. Lancet 368: 1681–1688. [PubMed]
23. Torrens JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, et al. (2004) Ethnic differences in insulin sensitivity and β-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care 27: 354–361. [PubMed]
24. Perry JR, Voight BF, Yengo L, Amin N, Dupuis J, et al. (2012) Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. PLoS Genet 8: e1002741. [PMC free article] [PubMed]
25. Sandholt CH, Vestmar MA, Bille DS, Borglykke A, Almind K, et al. (2011) Studies of metabolic phenotypic correlates of 15 obesity associated gene variants. PLoS One 6: e23531. [PMC free article] [PubMed]
26. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segrè AV, et al. (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44: 981–990. [PMC free article] [PubMed]
27. Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, et al. (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341: 149–152. [PubMed]
28. Klein R, Nanduri V, Jing SA, Lamballe F, Tapley P, et al. (1991) The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 66: 395–403. [PMC free article] [PubMed]
29. Cassiman D, Denef C, Desmet VJ, Roskams T (2001) Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology 33: 148–158. [PubMed]
30. Mousavi K, Jasmin BJ (2006) BDNF is expressed in skeletal muscle satellite cells and inhibits myogenic differentiation. J Neurosci 26: 5739–5749. [PubMed]
31. Lommatzsch M, Braun A, Mannsfeldt A, Botchkarev VA, Botchkareva NV, et al. (1999) Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived neurotrophic functions. Am J Pathol 155: 1183–1193. [PubMed]
32. Ukropec J, Ukropcova B, Kurdiova T, Gasperikova D, Klimes I (2008) Adipose tissue and skeletal muscle plasticity modulates metabolic health. Arch Physiol Biochem 114: 357–368. [PubMed]
33. Kernie SG, Liebl DJ, Parada LF (2000) BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19: 1290–1300. [PubMed]
34. Rios M, Fan G, Fekete C, Kelly J, Bates B, et al. (2001) Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15: 1748–1757. [PubMed]
35. Nonomura T, Tsuchida A, Ono-Kishino M, Nakagawa T, Taiji M, et al. (2001) Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice. Int J Exp Diabetes Res 2: 201–209. [PMC free article] [PubMed]
36. Han JC, Liu QR, Jones M, Levinn RL, Menzie CM, et al. (2008) Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med 359: 918–927. [PMC free article] [PubMed]
37. Gray J, Yeo GS, Cox JJ, Morton J, Adlam AL, et al. (2006) Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 55: 3366–3371. [PMC free article] [PubMed]
38. Ong C, Han JC, Hyde TM, Lipska BK, Mou Z, et al. (2010) Associations of single nucleotide polymorphisms (SNPs) in brain-derived neurotrophic factor (BDNF) with BDNF expression in human ventromedial hypothalamus (VMH) and with body mass index. Obesity 18: S61–S62.
39. Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, et al. (2007) Brain-derived neurotrophic factor (BDNF) and type 2diabetes. Diabetologia 50: 431–438. [PubMed]
40. Liao GY, An JJ, Gharami K, Waterhouse EG, Vanevski F, et al. (2012) Dendritically targeted BDNF mRNA is essential for energy balance and response to leptin. Nat Med 18: 564–571. [PMC free article] [PubMed]
41. Wen W, Cho YS, Zheng W, Dorajoo R, Kato N, et al. (2012) Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet 44: 307–311. [PMC free article] [PubMed]
Articles from PLoS ONE are provided here courtesy of
Public Library of Science